Diaceutics (GB:DXRX) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Diaceutics PLC has expanded its precision medicine services for rare diseases, including the addition of new genomic lab data partners and the enhancement of its data processing capabilities. This expansion has enabled Diaceutics to secure a new contract aimed at supporting the commercialization of a therapy for a rare genetic disorder, demonstrating the company’s commitment to improving early diagnosis and treatment for patients with rare diseases.
For further insights into GB:DXRX stock, check out TipRanks’ Stock Analysis page.
